| 000 | 01438 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517155549.0 | ||
| 264 | 0 | _c20180223 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1476-5454 | ||
| 024 | 7 |
_a10.1038/eye.2017.87 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMutlu, M | |
| 245 | 0 | 0 |
_aAqueous humor pentraxin-3 levels in patients with diabetes mellitus. _h[electronic resource] |
| 260 |
_bEye (London, England) _cOct 2017 |
||
| 300 |
_a1463-1467 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAqueous Humor _xmetabolism |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Retinopathy _xetiology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSerum Amyloid P-Component _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aYuksel, N | |
| 700 | 1 | _aTakmaz, T | |
| 700 | 1 | _aDincel, A S | |
| 700 | 1 | _aBilgihan, A | |
| 700 | 1 | _aAltınkaynak, H | |
| 773 | 0 |
_tEye (London, England) _gvol. 31 _gno. 10 _gp. 1463-1467 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/eye.2017.87 _zAvailable from publisher's website |
| 999 |
_c27239237 _d27239237 |
||